Product Images Phyrago
View Photos of Packaging, Labels & Appearance
- image description - Untitled
- carton-100 - carton 100
- carton-140 - carton 140
- core-20 - carton 20
- carton-50 - carton 50
- carton-70 - carton 70
- carton-80 - carton 80
- label-100 - label 100
- label-140 - label 140
- label-20 - label 20
- label-50 - label 50
- label-70 - label 70
- label-80 - label 80
- structure - structure
Product Label Images
The following 14 images provide visual information about the product associated with Phyrago NDC 70709-155 by Cycle Pharmaceuticals Ltd, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
carton-100 - carton 100

This text is a label for PHYRAGO tablets containing dasatinib, a hazardous drug that should not be crushed, cut, or chewed, but swallowed whole. Each tablet has 100 mg of dasatinib. It provides information on dosage, storage conditions (20°C to 25°C) and manufacturer details for Cycle Pharmaceuticals Ltd in the UK. The NDC number for the tablets is 70709-155-10.*
carton-140 - carton 140

The text provides information about a medication called PHYRAGO™ (dasatinib) in tablet form. It includes instructions to not use the product if the inner seal of the bottle is broken or missing, storage temperature recommendations, a warning about it being a hazardous drug, and directions to swallow the tablets whole without crushing, cutting, or chewing them. The tablets are packaged in a bottle containing 30 tablets. The manufacturer is Cycle Pharmaceuticals Ltd based in Cambridy.*
carton-50 - carton 50

PHYRAGO™ is a hazardous drug containing dasatinib that comes in tablet form. It is essential not to crush, cut, or chew the tablets and to swallow them whole. Each tablet contains 50 mg of dasatinib. The medication should be stored at room temperature between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C and 30°C (59°F and 86°F). The prescription information should be consulted for proper dosage guidance. Manufactured by Cycle Pharmaceuticals Ltd in the UK.*
carton-70 - carton 70

This is a description for PHYRAGO™ (dasatinib) Tablets. There are 60 tablets in each bottle with the NDC number 70709-153-70. The dosage information is available in the prescribing information. It is important not to use if the inner seal of the bottle is broken or missing. These tablets are classified as a Hazardous Drug. Instructions state not to crush or chew tablets; they should be swallowed whole. The manufacturer of PHYRAGO™ is Cyle Pharmaceuticals Ltd, located in Cambridge, UK.*
carton-80 - carton 80

This text contains information about a medication labeled as "PHYRAGO" with the active ingredient dasatinib. Each tablet contains 80 mg of dasatinib. It is advised to store the medication at a temperature between 20°C to 25°C (68°F to 77°F). The text mentions a warning that it is a hazardous drug and should not be crushed, cut, or chewed; tablets should be swallowed whole. It also gives information regarding the dosage and prescribing details. The text includes a unique identification code, "A000231," and mentions a specific number of tablets in the pack.*
label-20 - label 20

This is a description of a pharmaceutical product with the name "PHYSIOLOGO™". It includes important instructions for use, such as swallowing the tablets whole and not crushing, cutting, or chewing them. The product comes in a package containing 60 tablets, and it appears to be related to a hazardous drug called dasatinib. Additionally, there are numbers and abbreviations that may refer to specific dosages or medical instructions.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.